Pharmaceutical companies are mining hospital and doctor files for cases where patients already took a drug in routine medical care
Drugmakers are trying to win drug approvals by parsing vast data sets of electronic medical records, shifting away from lengthy, and costly, clinical trials in patients.
Pfizer Inc., Johnson & Johnson and Amgen Inc. are among the drugmakers that have submitted the data-mining analyses to the U.S. Food and Drug Administration in seeking approval to sell new medicines or for new uses for older ones. The FDA has approved new uses for breast cancer, bladder cancer and leukemia drugs in part based on the data.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eisai Inc announces U.S. approval for insomnia drugJapan-based drugmaker Eisai Co's U.S. subsidiary announced on Sunday that i...
Read more »
Buttigieg leads 2020 rivals in Wall Street contributionsWhile Buttigieg is hardly alone in turning to the finance industry for support, the data could leave him exposed to further attacks from his progressive rivals, especially Sen. Elizabeth Warren.
Read more »
Tattoo removal company seeks to ride a wave of millennial 'regretters'Tattoo removal treatment has remained an expensive and painful procedure for decades.
Read more »
Best day to travel ahead of Christmas? Tuesday, forecasters sayThe best times to drive during this holiday week, to avoid inclement weather
Read more »
'The Affair' EP Sarah Treem responds to Ruth Wilson exit controversy: 'I tried to protect her'Sarah Treem is telling her side of the story. Late on Friday, the showrunner of The Affair shared a lengthy…
Read more »